Xultant Organosynth

Mumbai, India Founded: 2003 • Age: 23 yrs
Offers custom synthesis and process development solutions for pharmaceutical companies.

About Xultant Organosynth

Xultant Organosynth was a Healthcare company based in Mumbai (India) founded in 2003. It offers custom synthesis and process development solutions for pharmaceutical companies. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Chemical Synthesis and Process Development. Its legal entity in India is Xultant Organosynth Private Limited (U72900MH2003PTC141513). Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Xultant Organosynth, established in 2003, excels in providing healthcare solutions, producing pharmaceutical products, chemical synthesis, and process development. Offers custom synthesis and process development solutions for pharmaceutical companies. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Board of directors of Xultant Organosynth Private Limited (Xultant Organosynth)

Xultant Organosynth Private Limited is the primary company behind Xultant Organosynth. The board of Xultant Organosynth Private Limited currently have 2 directors; the longest-serving is Ramesh Patodia, appointed in 2003.

DirectorDesignationAppointedTenureEntity
Ramesh Patodia
DIN 01872926
Director28 Jul 200323 yrs 3 moXultant Organosynth Private Limited
Mitu Patodia
DIN 01872917
Director28 Jul 200323 yrs 3 moXultant Organosynth Private Limited

Similar companies to Xultant Organosynth

Xultant Organosynth has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Xultant Organosynth

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Xultant Organosynth

Xultant Organosynth was founded in 2003.

Xultant Organosynth is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Xultant Organosynth, established in 2003, excels in providing healthcare solutions, producing pharmaceutical products, chemical synthesis, and process development. Offers custom synthesis and process development solutions for pharmaceutical companies. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Xultant Organosynth's top competitors include Laurus Labs, Symbiotec and SeQuent.

Xultant Organosynth operates through Xultant Organosynth Private Limited.

The legal entities of Xultant Organosynth currently have 2 directors, including Ramesh Patodia, Mitu Patodia.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available